FDA Approves First Biosimilar Drug for Treatment of Wet AMD

Posted on November 29, 2021November 29, 2021 by Dan Roberts

November 29, 2021

FDA Approves First Biosimilar Drug for Treatment of Wet AMD

The U.S. Food and Drug Administration (FDA) has approved Byooviz (ranibizumab-nuna) as the first biosimilar to Lucentis (ranibizumab injection) for the treatment of wet AMD. Byooviz is also approved to treat macular edema and myopic choroidal neovascularization, a vision-threatening complication of myopia (nearsightedness). The drug is administered by intravitreal injection (delivered into the vitreous humor […]

Also posted in

Latest News
Therapies, Treatments, and Procedures

FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)

Posted on October 22, 2021April 2, 2022 by Dan Roberts

October 22, 2021

FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)

Susvimo, previously called Port Delivery System with ranibizumab, is the first wet AMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a month. By continuously delivering medicine into the eye through a refillable implant, Susvimo may help people with wet AMD maintain their vision with as […]

Also posted in

Latest News
Therapies, Treatments, and Procedures

Living Well With Low Vision: Miscellaneous Thoughts

Posted on June 25, 2021September 17, 2022 by Dan Roberts

June 25, 2021

Living Well With Low Vision: Miscellaneous Thoughts

by Dan Roberts Table of Contents About the Author I’m Visually Impaired, But . . . Twenty Things Eye Doctors Probably Don’t Tell You (But Would Like You To Know) Catching The Big One Correcting Misconceptions About AMD Detours Every Patient Can Be an Advocate Former Driver, Retired With Honor Hidden Disabilities: A Social Dilemma […]

Also posted in

Essay
Patients' Writings

Port Delivery System Under Priority Review by FDA

Posted on June 24, 2021April 2, 2022 by Dan Roberts

June 24, 2021

Port Delivery System Under Priority Review by FDA

Frequent Eye Injections May Soon Be History Genentech Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) is giving priority review for the company’s Port Delivery System for the treatment of wet age-related macular degeneration (AMD). If approved, PDS will be a first-of-its-kind therapeutic approach, offering people living with wet AMD an alternative […]

Also posted in

Latest News
Research and Developments

Rising Above COVID19 Depression

Posted on June 20, 2021June 20, 2021 by Dan Roberts

June 20, 2021

Rising Above COVID19 Depression

Prevalence of all forms of depression during the COVID19 pandemic was found to be 20% in a study population of 113,285 individuals.(1) Not unexpectedly, this is higher than the pre-pandemic rate. Compounded with already high levels of depression among those who are socially isolated due to visual impairment (2), this gives cause for increased concern […]

Also posted in

Age-Reversal Diet and Lifestyle Plan May Slow AMD Development

Posted on June 11, 2021June 13, 2021 by Dan Roberts

June 11, 2021

Age-Reversal Diet and Lifestyle Plan May Slow AMD Development

Several studies have identified specific nutrients and healthy behaviors as effective in delaying the development and slowing the progression of age-related diseases like macular degeneration. It has been said that the best cure for age-related macular degeneration (AMD) is to simply stop growing older. Now a pilot study of 43 men ages 50 to 72 […]

Also posted in

Health and Nutrition
Latest News

New AMD Treatments Coming Soon

Posted on May 16, 2021April 2, 2022 by Dan Roberts

May 16, 2021

New AMD Treatments Coming Soon

Sometimes it seems that retina research moves at a snail’s pace, but science is steadily moving toward those treatments and cures that will keep our eyes healthy. This is an update on four therapeutics just around the corner for treatment of age-related macular degeneration (AMD). Of the hundreds of ongoing clinical trials for both wet […]

Also posted in

Neovascularization May Slow Progression of Geographic Atrophy

Posted on April 8, 2021 by Dan Roberts

April 8, 2021

Neovascularization May Slow Progression of Geographic Atrophy

Neovascularization, or new blood vessel growth, is a restorative function of the body that assists in healing. When it occurs in the retina, however, it can lead to vision loss. In age-related macular degeneration (AMD) the photoreceptor cells weaken over time. In about 10 to 15 percent of AMD patients, the inflammatory system sends new […]

Also posted in

Latest News
Research and Developments

New Website Brings AMD Groups Together

Posted on March 25, 2021April 2, 2022 by Dan Roberts

March 25, 2021

New Website Brings AMD Groups Together

AMD Central.org provides access to resources for patients and caregivers in one location The American Macular Degeneration Foundation, BrightFocus Foundation, MD Support, Prevent Blindness and The SupportSight Foundation have launched AMD Central, an online resource that curates trusted information and tools from leading advocacy organizations to support the age-related macular degeneration (AMD) patient and caregiver community. […]

Also posted in

Daily Living
Latest News

Don’t Blame Everything On Your Macula

Posted on March 17, 2021March 17, 2021 by Dan Roberts

March 17, 2021

Don’t Blame Everything On Your Macula

So your sight is slowly diminishing, and your ophthalmologist told you that nothing could be done. They said that the cells in the very center of your retina (the macula) are degenerating, and gradual loss of clear eyesight is to be expected. Still, they want to see you at least once a year unless you […]

News & Archive Categories

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in

Also posted in